References

Advice

Amdipharm Mercury Company Limited (2012) Robinul powder. [online; accessed 23 April 2013]

Amdipharm Mercury Company Limited (2012) Glycopyrrolate Injection U.S.P. 200 micrograms/ml, 1ml & 3ml. [online; accessed 23 April 2013]

Allergan Ltd (2012) Botox 50 units. [online; accessed 1 May 2013]

Bajaj V, Langtry JA (2007) Use of oral glycopyrronium bromide in hyperhidrosis. British Journal of Dermatology 157: 118–21

Center for Drug Evaluation and Research. Application number: 022571Orig1s000. Labelling: Cuvposa [online; accessed 16 May 2013]

Clinical Knowledge Summaries (2009) Hyperhidrosis [online; accessed 16 May 2013]

General Medical Council (2013) Prescribing guidance: prescribing unlicensed medicines. [online; accessed 23 April 2013]

Health and Social Care Information Centre (2013) Prescription cost analysis - England 2012. [online; accessed 23 April 2013]

Lee HH, Kim DW, Kim DW et al. (2012) Efficacy of glycopyrrolate in primary hyperhidrosis patients. The Korean Journal of Pain 25: 28–32

National Health Service England and Wales (2013) NHS electronic drug tariff. [online; accessed 22 May 2013]

Novartis Pharmaceuticals UK Ltd (2012) Seebri Breezhaler inhalation powder, hard capsules 44mcg. [online; accessed 23 April 2013]

Paller AS, Shah PR, Silverio AM et al. (2012) Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis. Journal of the American Academy of Dermatology 67: 918–23

Shams K, Rzany BJ, Prescott LE et al. Interventions for excessive sweating of unknown cause. Cochrane review protocol DOI: 10.1002/14651858.CD002953.pub2, published online: 5 Oct 2011